Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

ALYZE

Explore full profile

Personalized health club with data-driven wellness plans

Bountiful, United StatesFounded 2025Health
Headcount <100 Current team size
Unlock exact values This page shows ranges. Dealroom has the exact numbers for ALYZE and the history behind them.

About ALYZE

ALYZE is a health, fitness, and wellness club that integrates medical diagnostics with personalized wellness plans. The company is launching its first physical location in Bountiful, Utah, in February 2026.

The core of ALYZE's business model is a mandatory 'anALYZE Assessment' for all members upon joining. This comprehensive evaluation establishes a baseline for physical, mental, and emotional health and includes a medical history intake, lifestyle and goals assessment, DEXA scan, extensive blood work, blood pressure reading, resting EKG, VO2Max test, and mental and physical fitness baselines. The data gathered from this assessment is used to create a personalized plan for each member.

ALYZE offers a wide array of services divided into several categories. Its 'Precision Medicine' services include Hormone Replacement Therapy (HRT), peptides like GLP-1s, IV therapy, and personalized supplement and nutrition plans. The 'Fitness' offerings encompass group classes such as reformer Pilates, yoga, and strength training, alongside an open gym and personal fitness plans. For 'Recovery,' members have access to saunas, cold plunges, hyperbaric oxygen therapy (HBOT), and red light beds. The club also features a 'MedSpa' for services like chemical peels and microneedling, and a 'MedLab' for ongoing diagnostic services. The business operates on a membership model which provides unlimited access to classes, recovery amenities, the gym, and ongoing support from performance coaches.

The company also sells its own line of supplements and health-related products like water purifiers and red light therapy devices. While its initial focus is the physical club in Utah, ALYZE plans a nationwide launch of its ALYZE+ App in 2026.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2025
Headquarters
Bountiful, United States
Employees
15
Open positions
None listed
Dealroom signal
74.7/100
Industry
Health, Sports
Sector
Health, Nutrition, Food as Medicine, medical testing
Client focus
b2c

Growth signals

ALYZE website traffic

Latest recorded traffic for ALYZE is 2.1K monthly website visits, down 25% over the last three months.

Latest monthly visits2.1K 3-month web change-25%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Bountiful HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about ALYZE on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ALYZE’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.